Regulation of E2F4 mitogenic activity during terminal differentiation by its heterodimerization partners for nuclear translocation

Cancer Research

Volumn 58, Issue 7, 1998, Pages 1325-1331

  Puri, Pier Lorenzo ^a,f   Cimino, Letizia ^a   Fulco, Marcella ^a   Zimmerman, Christian ^b   La Thangue, Nicholas B ^d   Giordano, Antonio ^e   Graessmann, Adolf ^b   Levrero, Massimo ^a,c,g  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g POLICLINICO UMBERTO I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR E2F; VIRUS LARGE T ANTIGEN;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SIMIAN VIRUS 40; TRANSCRIPTION REGULATION;

ANIMALS; CELL CYCLE; CELL NUCLEUS; CELLS, CULTURED; CYTOPLASM; DIMERIZATION; DNA; DNA-BINDING PROTEINS; DROSOPHILA PROTEINS; E2F4 TRANSCRIPTION FACTOR; GENETIC VECTORS; GROWTH SUBSTANCES; MICE; MICROINJECTIONS; MUSCLES; SUBCELLULAR FRACTIONS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC; UP-REGULATION;

EID: 0032053727     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. La Thangue, N. B. DP and E2F proteins: components of a heterodimeric transcription factor implicated in cell cycle control. Curr. Opin. Cell. Biol., 6: 443-450, 1994.
2. Chittenden, T., Livingston, D. M., and De Caprio, J. A. Cell cycle analysis of E2F in primary T cells reveals novel E2F complexes and biochemically distinct forms of free E2F. Mol. Cell. Biol., 13: 3975-3983, 1993.
3. Shin, E. K., Shin, A., Paulding, C., Schaffausen, B., and Yee, A. S. Multiple changes in E2F function occur upon muscle differentiation. Mol. Cell. Biol., 15: 2252-2262, 1995.
4. Corbeil, H. B., Whyte, P., and Branton, P. E. Characterization of transcription factor E2F complexes during muscle and neuronal differentiation. Oncogene, 11: 909-920, 1995.
5. Jiang, H., Lin, J., Young, S-M., Goldestein, N. I., Waxman, S., Davila, V., Chellapan, S. P., and Fisher, P. B. Cell cycle gene expression and E2F transcription factor complexes in human melanoma cells induced to terminally differentiate. Oncogene, 11: 1179-1189, 1995.
6. Puri, P. L., Balsano, C., Burgio, V. L., Chirillo, P., Natoli, G., Ricci, L., Mattei, E., Graessmann, A., and Levrero, M. MyoD prevents cyclin A/cdk2 containing E2F complexes formation in terminally differentiated myocytes. Oncogene, 14: 1171-1184, 1997.
7. Wang, J., Helin, K., Jin, P., and Nadal-Ginard, B. Inhibition of in vitro myogenic differentiation by cellular transcription factor E2F1. Cell Growth Differ., 6: 1299-1306, 1995.
8. Weintraub, S. J., Prater, C. A., and Dean, D. C. Retinoblastoma protein switches the E2F sites from positive to negative. Nature (Lond.), 358: 259-261, 1992.
9. Bandara, L., Buck, V., Zamanian, M., Johnston, L., and La Thangue, N. B. Functional synergy between DP1 and E2F1 in the cell cycle regulating transcription factor DRTF1/E2F. EMBO J., 12: 4314-4324, 1993.
10. Helin, K., Wu, C-L., Fattaey, A. R., Lees, J. A., Dynlacht, B. D., Ngwu, C., and Harlow, E. Heterodimerization of the transcription factors E2F1 and DP1 leads to cooperative trans-activation. Genes Dev., 7: 1850-1861, 1992.
11. Krek, W., Livingston, D. M., and Shirodkar, S. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science (Washington DC), 262: 1557-1559, 1993.
12. Krek, W., Ewen, M., Shirodkar, S., Arany, Z., Kaelin, W., and Livingston, D. Negative regulation of the growth promoting transcription factor E2F1 by a stably bound cyclin A-dependent protein kinase. Cell, 78: 161-172, 1994.
13. Lees, E., Faha, B., Dulic, V., Reed, S., and Harlow, E. Cyclin E/cdk2 and Cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev., 6: 1874-1885, 1994.
14. Vairo, G., Livingston, D. M., and Ginsberg, D. Functional interaction between E2F4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma family members. Genes Dev., 9: 869-881, 1995.
15. Tommasi, S., and Pfeiffer, G. P. In vivo structure of the human cdc2 promoter: release of a p130-E2F4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression. Mol. Cell. Biol., 15: 6901-6913, 1995.
16. Zwicker, J., Liu, N., Engeland, K., Lucibello, F. C., and Muller, R. Cell cycle regulation of E2F site occupation in vivo. Science (Washington DC), 271: 1595-1597, 1996.
17. Mihara, K., Cao, X-R., Yen, A., Chandler, S., Driscoll, B., Murphree, A. L., Tang, A., and Fung, Y-K. T. Cell cycle dependent regulation of phosphorylation of the human retinoblastoma gene product. Science (Washington DC), 246: 1300-1303, 1989.
18. Lin, B. T-Y., Gruenwald, S., Morla, A. O., Lee, W-H, and Wang, Y. J. Y. Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. EMBO J., 10: 857-864, 1992.
19. Hinds, P. W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S. I., and Weinberg, R. A. Regulation of retinoblastoma protein function by ectopic expression of human cyclins. Cell, 70: 993-1006, 1992.
20. Beijersbergen, R. L., Carlee, L., Kerkhoven, R. M., and Bernard, R. Regulation of the retinoblastoma protein-related p107 by cyclin complexes. Genes Dev., 9: 1340-1353, 1995.
21. Baldi, A. De Luca, A., Claudio, P. P., Baldi, F., Giordano, G. G., Tommasino, M., Paggi, M., and Giordano, A. The Rb2/p130 gene product is a nuclear protein whose phosphorylation is cell cycle regulated. J. Cell. Biochem., 59: 402-408, 1995.
22. Claudio, P. P., De Luca, A., Haward, C. M., Baldi, A., Firpo, E. J., Koff, A., Paggi, M. G., and Giordano, A. Functional analysis of pRb2/p130 interaction with cyclins. Cancer Res., 56: 2003-2008, 1996.
23. Nadal-Ginard, B. Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis. Cell, 15: 855-864, 1978.
24. Halevy, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D., and Lassar A. B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science (Washington DC), 267: 1018-1021, 1995.
25. Guo, K., Wang, J., Andres, V., Smith, R., and Walsh, K. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell. Biol., 15: 3823-3829, 1995.
26. Kiess, M., Gill, M., and Hamel, P. Expression and activity of the retinoblastoma protein (pRb) family proteins, p107 and p130, during L6 myoblasts differentiation. Cell Growth Differ., 6: 1287-1298, 1995.
27. De Luca, A., MacLachlan, T. K., Bagella, L., Dean, C., Howard, C. M., Claudio, P. P., Baldi, A., Khalili, K., and Giordano, A. A unique domain of pRb2/p130 acts as an inhibitor of cdk2 kinase activity. J. Biol. Chem., 272: 20971-20974, 1997.
28. Magae, J., Wu, C-L., Illenye, S., Harlow, E., and Heintz, N. H. Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members. J. Cell Sci., 109: 1717-1726, 1996.
29. de la Luna, S., Burden, M. J., Lee, C-W., and La Thangue, N. B. Nuclear accumulation of the E2F heterodimer regulated by subunit composition and alternative splicing of a nuclear localization signal. J. Cell Sci., 109: 2443-2452, 1996.
30. Graessmann, A., and Graessmann, M. Microinjection of tissue culture cells. Methods Enzymol., 101: 482-492, 1983.
31. Johnson, D. G., Schwarz, J. K., Cress, W. D., and Nevins J. R. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature (Lond.), 365: 349-352, 1993.
32. Qin, X-Q., Livingston, D. M., Kaelin, W. G., and Adams, P. Deregulated transcription factor E2F1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA, 91: 10918-10922, 1994.
33. Wu, X., and Levine, A. J. p53 and E2F1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA, 91: 3602-3606, 1994.
34. Shan, B., and Lee, W-H. Deregulated expression of E2F1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol., 14: 8166-8173, 1994.
35. Lukas, J., Petersen, B. O., Holm, K., Bartek, J., and Helin, K. Deregulated expression of E2F family members induces S-phase entry and overcomes p16-mediated growth suppression. Mol. Cell. Biol., 16: 1047-1057, 1996.
36. Kirshenbaum, L. A., Abdellatif, M., Chakraborty, S., and Schneider, M. D. Human E2F-1 reactivates cell cycle progression in ventricular myocytes and represses cardiac gene transcription. Dev. Biol., 179: 402-411, 1996.
37. Gu, W., Schneider, J. W., Condorelli, G., Kaushal, S., Mahdavi, V., and Nadal-Ginard, B. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell, 72: 309-324, 1993.
38. Endo, T., and Goto, S. Retinoblastoma gene product Rb accumulates during myogenic differentiation and is deinduced by expression of SV40 large T antigen. J. Biochem. (Tokyo), 112: 427-430, 1992.
39. Martelli, F., Cenciarelli, C., Santarelli, G., Polikar, B., Felsani, A., and Caruso, M. MyoD induces retinoblastoma gene expression during myogenic differentiation. Oncogene, 9: 3579-3590, 1994.
40. Cardoso, M. C., Leonhardt, H., and Nadal-Ginard, B. Reversal of terminal differentiation and control of DNA replication: cyclin A and cdk2 specifically localize at subnuclear sites of DNA replication. Cell, 74: 976-992, 1993.
41. Crescenzi, M., Soddu, S., and Tatò, F. Mitotic cycle reactivation in terminally differentiated cells by adenovirus infection. J. Cell. Physiol., 162: 26-35, 1995.
42. Tiainen, M., Spitkovsky, D., Jansen-Durr, P., Sacchi, A., and Crescenzi, M. Expression of E1A in terminally differentiated muscle cells reactivates the cell cycle and suppresses tissue-specific genes by separable mechanisms. Mol. Cell. Biol., 16: 5302-5312, 1996.
43. Puri, P. L., Avantaggiati, M. L., Balsano, C., Sang, N., Graessmann, A., Giordano, A. A., and Levrero, M. p300 is required for MyoD-dependent cell cycle arrest and muscle specific gene transcription. EMBO J., 16: 369-383, 1997.
44. Lindeman, G. J., Gaubatz, S., Livingston, D. M., and Ginsberg, D. The subcellular localization of E2F4 is cell cycle-dependent. Proc. Natl. Acad. Sci. USA, 94: 5095-5100, 1997.
45. Muller, H., Moroni, M. C., Vigo, E., Petersen, B. O., Bartek, J., and Helin, K. Induction of S-phase entry by E2F transcription factors depends on their nuclear localization. Mol. Cell. Biol., 17: 5508-5520, 1997.
46. Schneider, J. W., Gu, W., Zhu, L., Mahdavi, V., and Nadal-Ginard, B. Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells. Science (Washington DC), 264: 1467-1471, 1994.
47. Claudio, P. P., Howard, C. M., Baldi, A., De Luca, A., Fu, Y., Condorelli, G., Sun, Y., Colburn, B., Calabretta, B., and Giordano, A. p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res., 54: 5556-5560, 1994.
48. Puri, P. L., Avantaggiati, M. L., Burgio, V. L., Chirillo, P., Collepardo, D., Natoli G., Balsano, C. A., and Levrero, M. Reactive oxygen intermediates mediate angiotensin II-induced cJun/cFos heterodimer DNA binding activity and proliferative/hypertrophic response in myogenic cells. J. Biol. Chem., 270: 22129-22134, 1995.
49. Verona, R., Moberg, K., Estes, S., Stare, M., Vernon, J. P., Lees, J. A. EZF activity is regulated by cell cycle-dependent changes in subcellular localization. Mol. Cell Biol., 17: 7268-7282, 1997.
50. Allen, K. E., de la Luna, S., Kerkhoven, Rm, Bernards, R., La Thangue, N.B. Distinct mechanisms of nuclear accumulation regulate the functional consequence of ELF transcription factors. J. Cell Sci., 110: 2819-2831, 1997.